CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- SC 13D Stake Beneficial Ownership Report
- 6-K Event Report of Foreign Issuer
- SC 13G Stake Amended Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CT ORDER Other Confidential Order
- CERTNAS Other Certification by the Nasdaq Stock Market
- EFFECT Other Notice of Effectiveness
- F-1MEF Other F-1MEF
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- F-1/A Offering Registration Statement for Certain Foreign Private Issuers
- 8-A12B Other Registration of Securities
- F-6 Other Registration of American Depositary Receipt Shares
- CORRESP Other Correspondence Between Filers and SEC Staff
- F-1/A Offering Registration Statement for Certain Foreign Private Issuers
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
Page 40 of 41 · 808 filings